San Diego Scientists Help Develop New Twist On In Vitro Fertilization
By David Wagner,
KPBS
| 11. 10. 2016
A team of researchers including scientists from San Diego have developed a new approach to in vitro fertilization that combines components from the eggs of two different women. They say if follow-up studies prove successful, it could one day improve treatments for infertility or help prevent devastating diseases.
But some experts are concerned that this and similar approaches, which have already reportedly been used in a number of human births, have not yet been proven safe.
The new technique involves extracting tiny cells called polar bodies from the egg of a woman who may be struggling with infertility or may be at risk of passing down mitochondrial disease to her children. Polar bodies normally play no role in fertilization, but they can when they're implanted into a healthier egg from a donor.
In a new study published Thursday in Cell Stem Cell, researchers co-led by the Salk Institute's Joseph Ecker show that when this hybrid egg is fertilized, it can give rise to cells that appear capable of becoming viable human embryos. These embryos could contain DNA from...
Related Articles
By Matt Novak, Gizmodo | 07.23.2025
Robert F. Kennedy Jr., the Secretary of Health and Human Services, has made a big push to get agencies like the Food and Drug Administration to use generative artificial intelligence tools. In fact, Kennedy recently told Tucker Carlson that AI...
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...